These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 10214863)
1. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells. Engel H; Drach J; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Goodacre A; Andreeff M Leukemia; 1999 Apr; 13(4):568-77. PubMed ID: 10214863 [TBL] [Abstract][Full Text] [Related]
2. Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission. Engel H; Goodacre A; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Andreeff M Br J Haematol; 1997 Oct; 99(1):64-75. PubMed ID: 9359505 [TBL] [Abstract][Full Text] [Related]
3. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. Bernell P; Jacobsson B; Nordgren A; Hast R Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444 [TBL] [Abstract][Full Text] [Related]
4. Pre-B acute lymphoblastic leukemia in a 3-year-old boy with pre-acute myelogenous leukemia myelodysplastic syndrome: cytogenetic evidence of common early progenitor cell ontogeny. Rossbach HC; Sutcliffe MJ; Chamizo W; Haag MM; Grana NH; Washington KR; Barbosa JL J Pediatr Hematol Oncol; 1998; 20(4):347-52. PubMed ID: 9703011 [TBL] [Abstract][Full Text] [Related]
5. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia. Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688 [TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization evaluation of minimal residual disease on stem-cell harvests. Díez-Martín JL; Buño I; Llamas P; Gosálvez J; López-Fernández C; Polo N; Regidor C Cancer Detect Prev; 2000; 24(2):169-72. PubMed ID: 10917138 [TBL] [Abstract][Full Text] [Related]
7. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia. Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650 [TBL] [Abstract][Full Text] [Related]
8. Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission. Feuring-Buske M; Haase D; Buske C; Hiddemann W; Wörmann B Leukemia; 1999 Mar; 13(3):386-92. PubMed ID: 10086729 [TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients. Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149 [TBL] [Abstract][Full Text] [Related]
10. Not the presence but the amount of clonal DNA detectable in remission of acute myeloid leukemia is predictive for relapse. Reif SW; Wiesner D; Duell T; Mittermueller J; Schmetzer HM Eur J Haematol; 2001 Oct; 67(4):207-20. PubMed ID: 11860441 [TBL] [Abstract][Full Text] [Related]
11. Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics. Trost D; Hildebrandt B; Müller N; Germing U; Royer-Pokora B Leuk Res; 2004 Feb; 28(2):171-7. PubMed ID: 14654082 [TBL] [Abstract][Full Text] [Related]
12. Hidden monosomy 7 in acute myeloid leukemia and myelodysplastic syndrome detected by interphase fluorescence in situ hybridization. Arif M; Tanaka K; Damodaran C; Asou H; Kyo T; Dohy H; Kamada N Leuk Res; 1996 Sep; 20(9):709-16. PubMed ID: 8947579 [TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study. Aktas D; Tuncbilek E Cancer Genet Cytogenet; 2006 Nov; 171(1):72-5. PubMed ID: 17074595 [TBL] [Abstract][Full Text] [Related]
14. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Guerci A; Merlin JL; Missoum N; Feldmann L; Marchal S; Witz F; Rose C; Guerci O Blood; 1995 Apr; 85(8):2147-53. PubMed ID: 7536492 [TBL] [Abstract][Full Text] [Related]
16. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia. Lezon-Geyda K; Najfeld V; Johnson EM Leukemia; 2001 Jun; 15(6):954-62. PubMed ID: 11417483 [TBL] [Abstract][Full Text] [Related]
17. Clonal analysis of progenitor cells by interphase cytogenetics in patients with acute myeloid leukemia and myelodysplasia. Van Der Lely N; Poddighe P; Wessels J; Hopman A; Geurts van Kessel A; De Witte T Leukemia; 1995 Jul; 9(7):1167-72. PubMed ID: 7630192 [TBL] [Abstract][Full Text] [Related]
18. Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7-associated myeloid disorders. Baurmann H; Cherif D; Berger R Leukemia; 1993 Mar; 7(3):384-91. PubMed ID: 8445944 [TBL] [Abstract][Full Text] [Related]
19. The monosomy 7 clone in interphase and metaphase cell population: a combined chromosome and primed in situ labeling study. Pedersen B; Koch J; Bendix Hansen K; Hindkjaer J; Lindbjerg Andersen C Acta Haematol; 1997; 97(4):216-21. PubMed ID: 9158664 [TBL] [Abstract][Full Text] [Related]
20. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype. Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]